(0ELV.L)
| Previous close | 35.85 |
| Open | 35.70 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 33.00 - 38.50 |
| 52-week range | 15.70 - 38.50 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 4.73M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireGuerbet : Q1 2024 revenue.
Q1 2024 revenue Quarterly activity Revenue: €194.3m, up 8.8% at CER1Growth remains particularly strong in Asia (+26.8% at CER) and the Americas (+20.1% at CER); the EMEA region (-6.2% at CER) was temporarily impacted by the reform of the supply of contrast products in France Annual targets confirmed Revenue: expected growth of over 8% like-for-like and at CERProfitability: restated EBITDA margin rate2 higher than in 2021 (14.4%) Villepinte, 25 April 2024, 5.45 pm: Guerbet (FR0000032526 GBT), a g
Globe NewswireGuerbet: Financial agenda for 2024
Financial agenda for 2024 Villepinte, 15 January 2024: Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2024. Publications calendar 2023 ANNUAL REVENUE February 08, 2024, after trading 2023 ANNUAL RESULTS March 20, 2024, after trading 2024 1ST QUARTER REVENUE April 25, 2024, after trading ANNUAL SHAREHOLDERS’ MEETING May 24, 2024 2024 2ND QUARTER REVENUE July 25, 2024, after trading 2024 FIRST HALF RESULTS Se
- Globe Newswire
GUERBET : Revenue at 30 September 2023.
Revenue at 30 September 2023 Activity 9-month revenue: €573.9 million, up 2.7% at CER1 Third-quarter sales remained very strong in Asia (+15.2% at CER), were stable in EMEA (+0.6%) and showed a smaller decline in the Americas (-5.2%)Expecting double-digit activity growth in the fourth quarter of 2023 thanks to the surge in sales of EluciremTM and strong momentum in Interventional Imaging Financial targets confirmed 2023 revenue up by more than 5% like-for-like and at CERRestated EBITDA margin2 o
